S-1/A: Inspire Veterinary Partners Files Amendment No. 1 to Form S-1, Registering Resale of 7,869,182 Shares
Sentiment:
Amendment to Registration Statement
Inspire Veterinary Partners aims to register the resale of up to 7,869,182 shares of Class A common stock by Tumim Stone Capital LLC, potentially raising up to $30 million.
Capital raiseThe company has entered into a purchase agreement with Tumim Stone Capital LLC, pursuant to which Tumim committed to purchase, subject to certain conditions and limitations, up to $30.0 million of shares of Class A Common Stock, at our direction from time to time, subject to the satisfaction of the terms and conditions in the Purchase Agreement.The company is pursuing a best-efforts offering to sell up to 26,581,605 shares of Class A Common Stock at an assumed offering price of $0.188, for anticipated gross proceeds of approximately $5 million.On January 2, 2024, we issued 20,000 shares of our Series A preferred stock to Target Capital 1, LLC (Target), an existing investor and holder of certain shares of our previously issued and outstanding Series A preferred stock, for gross proceeds of $200,000, pursuant to a subscription agreement between Inspire and Target in the form attached as Exhibit 10.16 and which is incorporated herein by reference.
Worse than expectedThe company's net loss increased significantly compared to the same period last year.The company is subject to a Nasdaq deficiency notice, indicating a low stock price.
Summary
- Inspire Veterinary Partners has filed an amendment to its Form S-1 registration statement to register the resale of up to 7,869,182 shares of Class A common stock.
- The shares are to be resold by Tumim Stone Capital LLC, under a purchase agreement where Inspire may sell up to $30 million in shares.
- Of the registered shares, 2,869,182 are commitment shares issued to Tumim as consideration for their commitment to purchase shares.
- An additional 5,000,000 shares of Class A Common Stock are also being registered for resale by Tumim.
- Inspire will not receive any proceeds from the resale of shares by Tumim, but may receive up to $30 million in gross proceeds from sales of Class A Common Stock to Tumim.
- The company intends to use any proceeds received from such sales to Tumim for working capital and general corporate purposes.
- The company is subject to a Nasdaq deficiency notice due to its stock price falling below $1.00, and has until May 28, 2024 to regain compliance.
- Inspire completed the acquisition of Valley Veterinary Services animal hospital on November 8, 2023, for $1.4 million plus assumed liabilities, consisting of $1 million in cash and 408,163 restricted shares of Class A common stock.
- On January 2, 2024, Inspire issued 20,000 shares of Series A preferred stock for gross proceeds of $200,000.
- Between November 14, 2023 and January 29, 2024, Series A preferred stock holders converted 416,641 shares of Series A preferred stock for 16,616,942 shares of Class A Common Stock.
- The company has filed an amended registration statement for a best-efforts offering of up to 26,581,605 shares of Class A Common Stock at an assumed offering price of $0.188, for anticipated gross proceeds of approximately $5 million.
- Spartan Capital Securities, LLC is acting as the exclusive placement agent for the best-efforts offering.
Sentiment
Score: 4
Explanation: The document presents a mixed picture. While there are potential positives like the Tumim agreement and acquisitions, the company's financial losses, Nasdaq deficiency notice, and reliance on future capital raises contribute to a negative sentiment.
Positives
- The agreement with Tumim Stone Capital provides a potential source of funding up to $30 million.
- The acquisition of Valley Veterinary Services expands the company's operations.
- The issuance of Series A preferred stock and the best-efforts offering represent opportunities to raise capital.
- Conversion of Series A preferred stock reduces potential dilution from preferred shares.
Negatives
- The company is subject to a Nasdaq deficiency notice, indicating a low stock price.
- The company will not receive any proceeds from the resale of shares by Tumim.
- The company has a limited operating history and is not profitable.
- The company may need to raise additional capital to achieve its goals.
Risks
- The company's limited operating history and lack of profitability pose a risk to its ability to continue as a going concern.
- Failure to regain compliance with Nasdaq listing requirements could lead to delisting.
- The company's reliance on acquisitions for growth carries integration and financial risks.
- The company's management team has limited experience as senior management of a public company.
- The company may not have access to the full amount available under the Purchase Agreement with Tumim.
- The trading price of the Class A common stock is volatile, which could result in substantial losses to investors.
Future Outlook
The company expects to continue to incur net losses for the foreseeable future as it continues its development and acquisition of veterinary hospitals and related veterinary servicing activities.
Industry Context
The document highlights the fragmented nature of the pet care industry and the company's strategy to expand through acquisitions, which is a common trend among veterinary service providers.
Comparison to Industry Standards
- The document mentions that the Company seeks to match the industry target metric of 70% to 80% of gross revenue being derived from services.
- Competitors range in size from the largest such as Mars and NVA, which collectively own approximately 4,000 hospitals, to other national and regional groups such as Pathway/Thrive, VetcCor, Southern Vet Partners, Community Veterinary Partners, and others.
Stakeholder Impact
- Shareholders face potential dilution from the issuance of new shares.
- Employees may be affected by the company's financial performance and ability to execute its growth strategies.
- Customers may benefit from the company's expansion and improved services.
- Suppliers and creditors are subject to the company's ability to meet its financial obligations.
Next Steps
- The company needs to regain compliance with Nasdaq listing requirements by May 28, 2024.
- The company will need to execute its growth strategies and manage its expenses effectively.
- The company will need to secure additional capital to fund its operations.
Key Dates
| Date | Description |
|---|---|
| 2020-12-02 | Inspire Veterinary incorporated in Delaware |
| 2021-01-11 | Company entered into three separate commercial loans with First Southern National Bank (FSB) as part of the Kauai Veterinary Clinic, LLC acquisition. |
| 2021-01-25 | Company acquired Kauai Veterinary Clinic, Inc. |
| 2021-06-25 | Company entered into a master line of credit loan agreement (MLOCA) with Wealth South a division of Farmers National Bank of Danville, Kentucky (FNBD). |
| 2021-08-20 | Company acquired the veterinary practice and related assets of Chiefland Animal Hospital |
| 2021-10-07 | Company acquired the veterinary practice and related assets of the Pets & Friends Animal Hospital |
| 2021-12-28 | Company entered into a capital market advisory agreement (the Advisory Agreement), dated as of December 28, 2021, with Exchange Listing, LLC (Exchange Listing) |
| 2022-01-14 | Company acquired the veterinary practice and related assets of Advanced Veterinary Care of Pasco |
| 2022-03-15 | Company acquired the veterinary practice and related assets of Lytle Veterinary Clinic in Texas |
| 2022-03-22 | Company acquired the veterinary practice and related assets of Southern Kern Veterinary Clinic in California |
| 2022-05-18 | Company acquired the veterinary practice and related assets of Bartow Animal Clinic in Bartow, Florida |
| 2022-06-15 | Company acquired the veterinary practice and related assets of Dietz Family Pet Hospital in Richmond, Texas |
| 2022-06-29 | Company converted into a Nevada c-corporation |
| 2022-07-29 | Company acquired the veterinary practice and related assets of Aberdeen Veterinary Clinic in Aberdeen, Maryland |
| 2022-08-12 | Company acquired the veterinary practice and related assets of All Breed Pet Care veterinary clinic in Newburgh, Indiana |
| 2022-08-18 | The MLOCA was amended and restated to terminate the revolving feature on the Revolving Line and convert the line of credit to a closed end draw note (Closed End Draw Note) that mature on August 18, 2024. |
| 2022-10-31 | Company acquired the veterinary practice and related assets of the Pony Express Veterinary Hospital, Inc. in Xenia, Ohio |
| 2022-12-09 | Company acquired the veterinary practice and related assets of Williamsburg Veterinary Clinic in Williamsburg, MA |
| 2022-12-16 | Company acquired the veterinary practice and related assets of The Old 41 Veterinary Clinic in Bonita Springs, FL |
| 2023-01-01 | Warrant issued to Kimball Carr, the Companys Chair, President and Chief Executive Officer, a warrant (the Carr Warrant) for up to 50,000 shares of Class A common stock as consideration of Mr. Carrs personal guaranty of certain loans of the Company. |
| 2023-06-30 | Company exchanged the Companys previously issued 12% original issue discount secured convertible notes held by Dragon Dynamic Catalytic Bridge SAC Fund, Target Capital 1 LLC and 622 Capital LLC, the Companys senior secured lenders, for an aggregate of 442,458 shares of Series A preferred stock |
| 2023-08-31 | Company closed its IPO of 1.6 million shares of class A common stock, at a public price of $4.00 per share. |
| 2023-11-08 | Company completed the acquisition of Valley Veterinary Services animal hospital |
| 2023-11-27 | Company was notified by the Listing Qualifications Department of the Nasdaq Capital Market that the Companys Class A Common Stock is subject to potential delisting from Nasdaq |
| 2024-01-02 | Company issued 20,000 shares of our Series A preferred stock to Target Capital 1, LLC |
| 2024-01-19 | Letter Agreement between the Company and Tumim |
| 2024-01-26 | Company filed an amended registration statement on Form S-1/A to register our public offering and sale, on a reasonable best-efforts basis, of up to 26,581,605 shares of Class A Common Stock at an assumed offering price of $0.188 |
| 2024-02-08 | On February 8, 2024, the last reported trading date for our Class A Common Stock, the closing price of our Class A Common Stock was $0.131 per share. |
| 2024-02-09 | Date of this prospectus |
| 2024-05-24 | If the aggregate number of Commitment Shares and Warrant Shares due to Tumim would exceed the Exchange Cap, and the Company has not obtained stockholder approval for the issuance of Class A Common Stock in excess of the Exchange Cap in accordance with the applicable rules of Nasdaq (or any eligible substitute exchange) by May 24, 2024, then the Company shall be obligated to pay to Tumim an amount in cash equal to $600,000 minus the value of the shares of Class A common stock issuable to Tumim as Commitment Shares and the value of the Warrant Shares issuable upon exercise of the Tumim pre-funded warrant. |
| 2024-05-28 | In accordance with Nasdaq Marketplace Rule 5810(c)(3)(A), we have been provided 180 calendar days, or until May 28, 2024, to regain compliance. |
| 2024-11-24 | If we fail to regain compliance with the Bid Price Rule before May 28, 2024 but meet all of the other applicable standards for initial listing on Nasdaq with the exception of the Bid Price Rule, then we may be eligible to have an additional 180 calendar days, or until November 24, 2024, to regain compliance with the Bid Price Rule. |
| 2026-12-31 | We may remain an emerging growth company until as late as December 31, 2026 |
Keywords
Inspire Veterinary Partners, Tumim Stone Capital, Class A Common Stock, resale, registration statement, acquisition, best-efforts offering, Nasdaq, delisting, veterinary
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.